Stock GTTX GENETETHER THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company GeneTether Therapeutics Inc.

Equities

GTTX

CA37187D1087

Biotechnology & Medical Research

Delayed Canadian Securities Exchange
Other stock markets
 15:45:02 21/05/2024 BST 		5-day change 1st Jan Change
0.025 CAD -54.55% Intraday chart for GeneTether Therapeutics Inc. -54.55% -37.50%
03-30 5,174,558 Common Shares of GeneTether Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024. CI
03-29 GeneTether Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

GeneTether Therapeutics Inc. is a Canada-based genetic medicines company focused on creating gene editing therapies based on its proprietary GeneTether platform. The Company's platform technology uses a proprietary method to tether donor deoxyribonucleic acid (DNA) templates to the genome editing complex, making the template readily available for use during the genome editing repair stage. By positioning a donor DNA template directly at the site of a double strand break, the Company's GeneTether platform drives the DNA repair process towards homology-directed repair (HDR), a cellular repair mechanism that incorporates the genetic information of a DNA template. It is building a discovery pipeline focused on the treatment of rare, monogenic diseases of the kidney and the skin. The Company's GeneTether platform may also allow for high fidelity engineering of cells to permanently deliver the therapeutic proteins necessary to treat certain genetic diseases.

Managers

Managers TitleAgeSince
R. Geoffrey Sargent FOU
 Founder 70 11/02/18
Roland Boivin CEO
 Chief Executive Officer 57 30/09/21
Jean Jen DFI
 Director of Finance/CFO 37 30/09/21

Members of the board

Members of the board TitleAgeSince
Garner William FOU
 Founder 58 11/02/18
Roland Boivin CEO
 Chief Executive Officer 57 30/09/21
Philip Jull BRD
 Director/Board Member 64 30/09/21
Andre Pereira Fraga Figueiredo BRD
 Director/Board Member 48 31/12/20
Daren Graham FOU
 Founder 52 11/02/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 38,744,674 8,712,873 ( 22.49 %) 0 22.49 %

Shareholders

NameEquities%Valuation
Garner William
61.99 %
23,978,313 61.99 % 1 M $
Andre Pereira Fraga Figueiredo
6.626 %
2,563,061 6.626 % 115 338 $
Daren Graham
6.286 %
2,431,508 6.286 % 109 418 $
R. Geoffrey Sargent
2.004 %
775,000 2.004 % 34 875 $
Philip Jull
0.3850 %
148,919 0.3850 % 6 701 $
Roland Boivin
0.3490 %
135,000 0.3490 % 6 075 $

Company contact information

GeneTether Therapeutics, Inc.

1665 Ellis Street Suite 301

V1Y 2B3, Kelowna

+

http://www.genetether.com
address GeneTether Therapeutics Inc.(GTTX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GENETETHER THERAPEUTICS INC. Stock GeneTether Therapeutics Inc.
-37.50% 710K
MODERNA, INC. Stock Moderna, Inc.
+53.18% 63.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.18% 41.83B
LONZA GROUP AG Stock Lonza Group AG
+40.01% 40.47B
CELLTRION, INC. Stock Celltrion, Inc.
-10.22% 27.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.50% 26.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.40% 18.69B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+2.81% 12.73B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+22.74% 12.11B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.31% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. GTTX Stock
  4. Company GeneTether Therapeutics Inc.